These genetic insights should be interpreted with a qualified healthcare provider and are not predictive of exact medication response or kidney safety
Routine Medical Appointments Regular appointments with healthcare providers are essential for monitoring the patients response to semaglutide
Data were obtained from adults with overweight or obesity who were prescribed semaglutide (Wegovy, Novo Nordisk) or a non-GLP-1 receptor agonist obesity medication from June 2021 to December 2022
Many clients report feeling more energized and less fatigued after treatment, which can enhance your ability to stick to your fitness and health goals
Step 2: Work With Your Provider These plans usually require prior authorization, so make sure your provider submits all required documentation, including diagnosis and justification
Biochemical and biophysical research communications , 280 (1), 132138